人卵巢重建的初步步骤:前窦卵泡在脱细胞人卵巢支架中的存活
本研究优化了人卵巢组织脱细胞方案,并用小鼠和人前窦卵泡及卵巢细胞再细胞化,在体外和免疫缺陷小鼠体内评估支架生物功能。0.1% SDS处理18-24小时可完全脱细胞且保留ECM,再细胞化后前窦卵泡可存活,异种移植后人卵泡存活率25%、小鼠卵泡恢复率21%,39%小鼠卵泡发育至窦阶段。
要点
- 0.1% SDS处理18-24小时可有效脱细胞人卵巢皮质和髓质组织,DNA含量较天然组织降低>90%。
- 脱细胞支架中胶原含量为天然样本基线的88-98%,胶原I和层粘连蛋白等ECM成分保留。
- 异种移植3周后卵泡恢复率人25%、小鼠21%,39%小鼠卵泡发育至窦阶段。
核心结论
- 首次证明分离的人卵泡可在脱细胞人卵巢支架中存活,该概念验证可能为消除既往癌症患者移植冻存卵巢组织时恶性细胞复发风险提供新策略。
研究设计与样本
- 优化人卵巢组织脱细胞方案,并在体外和体内用小鼠及人前窦卵泡和卵巢细胞再接种测试脱细胞支架的生物功能性。
- 人卵巢组织和分离的前窦卵泡来自接受卵巢组织冻存以保留生育力的女性。
- 小鼠前窦卵泡N=241和人前窦卵泡N=20接种于脱细胞支架并皮下移植至免疫缺陷小鼠3周。
主要发现
- 0.1% SDS孵育18-24小时可充分脱细胞人卵巢髓质和皮质组织,消除所有细胞并保持ECM完整。
- 脱细胞组织DNA含量较天然组织样本降低>90%,PAS染色确认完全脱细胞且未见可见核物质。
- 脱细胞组织胶原I染色阳性,胶原含量为天然样本各自基线的88-98%。
- 人卵巢基质细胞可再细胞化脱细胞支架,分离的人前窦卵泡在共培养中保持存活。
- 异种移植后脱细胞支架支持人卵泡存活和小鼠卵泡生长,39%小鼠卵泡发育至窦阶段;3周移植后卵泡恢复率人25%、小鼠21%。
局限性
- 需要进一步研究以提高再接种卵泡的恢复率和存活率。
- 应评估更长的移植期以确定人卵泡的发育潜能。
- 卵泡存活可能因缺乏基质细胞而受损。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can a reconstructed ovary using decellularized human ovarian tissue (DCT) support survival of pre-antral stage follicles? SUMMARY ANSWER: We have demonstrated an effective protocol for decellularization of human ovarian tissues and successful recellularization with isolated human ovarian cells and pre-antral follicles. WHAT IS KNOWN ALREADY: Survivors of leukemia or ovarian cancer run a risk of reintroducing malignancy when cryopreserved ovarian tissue is transplanted to restore fertility. A reconstructed ovary free of malignant cells could provide a safe alternative. Decellularization of ovarian tissue removes all cells from the extracellular matrix (ECM) including possible malignancies and leaves behind a physiological scaffold. The ECM offers the complex milieu that facilitates the necessary interaction between ovarian follicles and their surroundings to ensure their growth and development. Previous studies have shown that decellularized bovine ovarian scaffolds supported murine follicle growth and restoration of ovarian function in ovariectomized mice. STUDY DESIGN, SIZE, DURATION: Optimizing a decellularization protocol for human ovarian tissues and testing biofunctionality of the decellularized scaffolds in vitro and in vivo by reseeding with both murine and human pre-antral follicles and ovarian cells. PARTICIPANTS/MATERIALS, SETTING, METHODS: Donated human ovarian tissue and isolated pre-antral follicles were obtained from women undergoing ovarian tissue cryopreservation for fertility preservation. Ovarian cortical and medullary tissues were decellularized using 0.1% sodium dodecyl sulfate (SDS) for 3, 6, 18 and 24 hours followed by 24 hours of 1 mg/mL DNase treatment and washing. Decellularization of ovarian tissues and preservation of ECM were characterized by morphological evaluation using Periodic Acid-Schiff (PAS) staining, DNA quantification, histochemical quantification of collagen content and immunofluorescence analysis for collagen IA, laminin, fibronectin and DNA. Human ovarian stromal cells and isolated human pre-antral follicles were reseeded on the DCT and cultured in vitro. Isolated murine (N = 241) and human (N = 20) pre-antral follicles were reseeded on decellularized scaffolds and grafted subcutaneously to immunodeficient mice for 3 weeks. MAIN RESULTS AND THE ROLE OF CHANCE: Incubation in 0.1% SDS for 18-24 hours adequately decellularized both human ovarian medullary and cortical tissue by eliminating all cells and leaving the ECM intact. DNA content in DCT was decreased by >90% compared to native tissue samples. Histological examination using PAS staining confirmed that the cortical and medullary tissues were completely decellularized, and no visible nuclear material was found within the decellularized sections. DCT also stained positive for collagen I and collagen quantities in DCT constituted 88-98% of the individual baselines for native samples. Human ovarian stroma cells were able to recellularize the DCT and isolated human pre-antral follicles remained viable in co-culture. Xenotransplantation of DCT reseeded with human or murine pre-antral follicles showed, that the DCT was able to support survival of human follicles and growth of murine follicles, of which 39% grew to antral stages. The follicular recovery rates after three weeks grafting were low but similar for both human (25%) and murine follicles (21%). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Further studies are needed to increase recovery and survival of the reseeded follicles. Longer grafting periods should be evaluated to determine the developmental potential of human follicles. Survival of the follicles might be impaired by the lack of stroma cells. WIDER IMPLICATIONS OF THE FINDINGS: This is the first time that isolated human follicles have survived in a decellularized human scaffold. Therefore, this proof-of-concept could be a potential new strategy to eliminate the risk of malignant cell re-occurrence in former cancer patients having cryopreserved ovarian tissue transplanted for fertility restoration. STUDY FUNDING/COMPETING INTEREST(S): This study is part of the ReproUnion collaborative study, co-financed by the European Union, Interreg V ÖKS. Furthermore, Project ITN REP-BIOTECH 675526 funded by the European Union, European Joint Doctorate in Biology and Technology of the Reproductive Health, the Research Pools of Rigshospitalet, the Danish Cancer Foundation and Dagmar Marshalls Foundation are thanked for having funded this study. The funders had no role in the study design, data collection and interpretation, or in the decision to submit the work for publication.
引用
- Pors SE, Ramløse M, Nikiforov D, et al. Initial steps in reconstruction of the human ovary: survival of pre-antral stage follicles in a decellularized human ovarian scaffold. Hum Reprod. 2019. PMID: 31286144. doi:10.1093/humrep/dez077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。